UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000031620
Receipt number R000035975
Scientific Title A randomized controlled trial of telecare and face to face consultation with CA-F17 based on the standard smoking cessation program for nicotine dependence.
Date of disclosure of the study information 2018/03/08
Last modified on 2019/09/03 16:04:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A randomized controlled trial of telecare and face to face consultation with CA-F17 based on the standard smoking cessation program for nicotine dependence.

Acronym

A randomized controlled trial of telecare and face to face consultation with CA-F17 based on the standard smoking cessation program for nicotine dependence.

Scientific Title

A randomized controlled trial of telecare and face to face consultation with CA-F17 based on the standard smoking cessation program for nicotine dependence.

Scientific Title:Acronym

A randomized controlled trial of telecare and face to face consultation with CA-F17 based on the standard smoking cessation program for nicotine dependence.

Region

Japan


Condition

Condition

nicotine dependence

Classification by specialty

Medicine in general Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Randomized, controlled non-inferiority study to assess the efficacy and safety of CA-F17 using telecommunications technology in addition to the standard smoking cessation treatment program as compared with face to face consultation.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

9-12 week Continuous Abstinence Rate

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment Behavior,custom

Interventions/Control_1

Intervention group:One-time dispense of CA-F17 in conjunction with 3months of Standard Treatment of Nicotine Dependence using telecommunications technology.

Interventions/Control_2

Control group:One-time dispense of CA-F17 in conjunction with 3 months of Standard Treatment of Nicotine Dependence with face to face consultation.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Cases using a smartphone, diagnosed as nicotine dependent on tobacco dependence screening test who intend to quit smoking immediately

Key exclusion criteria

Cases judged difficult to participate in the trial, such as severe mental illness

Target sample size

114


Research contact person

Name of lead principal investigator

1st name Akihiro
Middle name
Last name Nomura

Organization

Kanazawa University Hospital

Division name

Innovative Research Center

Zip code

9200934

Address

13-1,Takaramachi, Kanazawa city, Ishikawa prefecture

TEL

076-265-2049

Email

anomura@med.kanazawa-u.ac.jp


Public contact

Name of contact person

1st name Tomoyasu
Middle name
Last name Muto

Organization

CureApp, Inc.

Division name

Clinical and Regulatory Affairs Department

Zip code

1030001

Address

12-5, Kodenmacho, Nihombashi, Chu-o-ku, Tokyo

TEL

03-6231-0183

Homepage URL


Email

clinreg_admin@cureapp.jp


Sponsor or person

Institute

CureApp, Inc.

Institute

Department

Personal name



Funding Source

Organization

CureApp, Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo-Eki Center-building Clinic Institutional Review Board

Address

3-3-14, Nihombashi, Chuo-ku, Tokyo, 103-0027, Japan

Tel

03-1526-6688

Email

info_tecc-irb@clinipro.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 03 Month 08 Day


Related information

URL releasing protocol

https://www.researchprotocols.org/2019/7/e12701/

Publication of results

Published


Result

URL related to results and publications

https://www.jmir.org/2019/4/e13520/

Number of participants that the trial has enrolled

115

Results

We randomized 115 participants with nicotine dependence: 58 were allocated to the telemedicine (internet-based video counseling) arm and 57, to the control (standard face-to-face clinical visit) arm. We analyzed all 115 participants for the primary outcome. Both telemedicine and control groups had similar CARs from weeks 9 to 12 (81.0% vs 78.9%; absolute difference, 2.1%; 95% CI -12.8 to 17.0), and the lower limit of the difference between groups (-12.8%) was greater than the prespecified limit (-15%).

Results date posted

2019 Year 09 Month 03 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2019 Year 01 Month 28 Day

Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 03 Month 08 Day

Date of IRB

2018 Year 03 Month 09 Day

Anticipated trial start date

2018 Year 03 Month 12 Day

Last follow-up date

2018 Year 12 Month 05 Day

Date of closure to data entry

2018 Year 12 Month 14 Day

Date trial data considered complete

2019 Year 01 Month 15 Day

Date analysis concluded

2019 Year 01 Month 17 Day


Other

Other related information



Management information

Registered date

2018 Year 03 Month 07 Day

Last modified on

2019 Year 09 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035975


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name